Cyber Kiosk Solutions Receives Its First Shipment Of Branded Saliva Drug Tests And Places Units For Sale In Florida

CORAL SPRINGS, Fla., July 1, 2014 /PRNewswire/ -- Cyber Kiosk Solutions, Inc. (PINKSHEETS: CYBK) has received its first shipment of CYBK branded saliva drug tests and has placed a number of units for sale in a Coral Springs smoke shop. Glass Springs Discount Smoke Shop owner Alex Baggiero states "I am happy to be the first business to offer CYBK's saliva drug tests to customers who may want a low cost way to test for pre-employment."

CYBK's Saliva Drug Tests are an orally administered test that will tell the user, within 10 minutes of being tested, the positive or negative results showing levels of Marijuana, Amphetamine, Benzodiazepines, Cocaine, Methamphetamine, Methadone, Morphine, and Phencyclidine. The cut-off levels are explained below:

FEATURES & BENEFITS

• Lot number and expiration date are included on the test kit pouch
• Available tests include: AMP, BZD, COC, M-AMP, OPI, THC
• Eliminates the need for controlled urine collections 
• Can be used anywhere and anytime for employment or pre-employment testing
• Results in 10 minutes

CYBK will market the Saliva Drug Tests to Smoke Shops in all states where they can offer their customers a low cost way to perform a pre-employment, self-administered drug screening. In addition to smoke shops, the Company will target medium to large businesses that administer random drug testing and are looking for a cost effective way to test employees. The results should be considered presumptive and should not be relied upon for law enforcement, but just as the Country embraced testing for alcohol to ensure drivers did not drive while impaired, CYBK's Saliva Drug Tests have the ability to do the same with THC levels. It is just a matter of time before States begin to regulate the amount of THC a user can test positive for before they are considered impaired and should not drive.

Cyber intends to market the Saliva Drug Tests to all facilities that dispense medical or recreational marijuana to aide in the responsible consumption of legalized marijuana by the consumer.  The Company expects the Saliva Drug Tests to be well received by all target markets and will release updates as the information becomes available.

The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

CONTACT:

Chris Clarke
[email protected]
954-509-3748

SOURCE Cyber Kiosk Solutions, Inc.